AMRX
Price
$7.75
Change
-$0.21 (-2.64%)
Updated
Jun 13 closing price
Capitalization
1.87B
54 days until earnings call
COLL
Price
$29.18
Change
-$0.42 (-1.42%)
Updated
Jun 13 closing price
Capitalization
1.24B
47 days until earnings call
Interact to see
Advertisement

AMRX vs COLL

Header iconAMRX vs COLL Comparison
Open Charts AMRX vs COLLBanner chart's image
Amneal Pharmaceuticals
Price$7.75
Change-$0.21 (-2.64%)
Volume$1.4M
Capitalization1.87B
Collegium Pharmaceutical
Price$29.18
Change-$0.42 (-1.42%)
Volume$227.49K
Capitalization1.24B
AMRX vs COLL Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. COLL commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and COLL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (AMRX: $7.75 vs. COLL: $29.18)
Brand notoriety: AMRX and COLL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 75% vs. COLL: 71%
Market capitalization -- AMRX: $1.87B vs. COLL: $1.24B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. COLL’s [@Pharmaceuticals: Other] market capitalization is $1.24B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileCOLL’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • COLL’s FA Score: 1 green, 4 red.
According to our system of comparison, COLL is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while COLL’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • COLL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than COLL.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.71% price change this week, while COLL (@Pharmaceuticals: Other) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

COLL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than COLL($1.24B). AMRX has higher P/E ratio than COLL: AMRX (90.00) vs COLL (30.17). COLL YTD gains are higher at: 1.850 vs. AMRX (-2.146). AMRX has higher annual earnings (EBITDA): 400M vs. COLL (308M). COLL has more cash in the bank: 311M vs. AMRX (91.5M). COLL has less debt than AMRX: COLL (674M) vs AMRX (2.75B). AMRX has higher revenues than COLL: AMRX (2.39B) vs COLL (567M).
AMRXCOLLAMRX / COLL
Capitalization1.87B1.24B151%
EBITDA400M308M130%
Gain YTD-2.1461.850-116%
P/E Ratio90.0030.17298%
Revenue2.39B567M422%
Total Cash91.5M311M29%
Total Debt2.75B674M408%
FUNDAMENTALS RATINGS
AMRX vs COLL: Fundamental Ratings
AMRX
COLL
OUTLOOK RATING
1..100
6774
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
5971
SMR RATING
1..100
9946
PRICE GROWTH RATING
1..100
5358
P/E GROWTH RATING
1..100
249
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COLL's Valuation (61) in the Pharmaceuticals Other industry is in the same range as AMRX (92) in the Pharmaceuticals Major industry. This means that COLL’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (59) in the Pharmaceuticals Major industry is in the same range as COLL (71) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to COLL’s over the last 12 months.

COLL's SMR Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that COLL’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Price Growth Rating (53) in the Pharmaceuticals Major industry is in the same range as COLL (58) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to COLL’s over the last 12 months.

COLL's P/E Growth Rating (9) in the Pharmaceuticals Other industry is in the same range as AMRX (24) in the Pharmaceuticals Major industry. This means that COLL’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXCOLL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 30 days ago
80%
Bullish Trend 19 days ago
71%
Declines
ODDS (%)
Bearish Trend 24 days ago
78%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JOEIX13.19N/A
N/A
JOHCM Emerging Markets Opps Advisor
FIKNX19.68N/A
N/A
Fidelity Advisor Small Cap Value Z
VIVIX67.63-0.55
-0.81%
Vanguard Value Index I
MADAX25.94-0.22
-0.84%
Madison Dividend Income A
GCSIX26.50-0.52
-1.92%
Goldman Sachs Small Cap Eq Insghts Instl

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-2.64%
PAHC - AMRX
46%
Loosely correlated
-2.37%
EBS - AMRX
40%
Loosely correlated
-5.30%
AMPH - AMRX
39%
Loosely correlated
-2.34%
ZTS - AMRX
39%
Loosely correlated
-2.66%
VTRS - AMRX
38%
Loosely correlated
-1.87%
More

COLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with AMPH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
-1.42%
AMPH - COLL
38%
Loosely correlated
-2.34%
ALKS - COLL
33%
Loosely correlated
-3.09%
AMRX - COLL
32%
Poorly correlated
-2.64%
RDY - COLL
32%
Poorly correlated
-2.29%
PAHC - COLL
31%
Poorly correlated
-2.37%
More